APOE Gene clinical trials
12 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
- Stem Cell Therapy for Early Alzheimer's Disease
- IMST for Dementia Risk Reduction
- Predicting Pre-dementia
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- Hearing Loss and Brain Health Study
- Vascular Intervention Strategies Trial for Alzheimer's
- A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)
- BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers
- GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “APOE Gene” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.